No Detail Found!

In-silico Analysis of Amotosalen Hydrochloride Binding to CD-61 of Platelets.

Author(s)
Hammad Tufail Chaudhary Department of Pathology, Medical College, Taif University, Taif, Saudi Arabia
Abstract
Objective: To determine the docking of Amotosalen hydrochloride (AH) at CD-61 of platelets, and to suggest the cause of bleeding in AH treated platelets transfusion. Study Design: Descriptive study. Place and Duration of Study: Medical College, Taif University, Taif, Saudi Arabia, from October 2014 to May 2015. Methodology: The study was carried out in-silico. PDB (protein data bank) code of Tirofiban bound to CD-61 was 2vdm. CD-61 was docked with Tirofiban using online docking tools, i.e. Patchdock and Firedock. Then, Amotosalen hydrochloride and CD-61 were also docked. Best docking poses to active sites of 2vdm were found. Ligplot of interactions of ligands and CD-61 were obtained. Then comparison of hydrogen bonds, hydrogen bond lengths, and hydrophobic bonds of 2vdm molecule and best poses of docking results were done. Patchdock and Firedock results of best poses were also analysed using SPSS version 16. Results: More amino acids were involved in hydrogen and hydrophobic bonds in Patchdock and Firedock docking of Amotosalen hydrochloride with CD-61 than Patchdock and Firedock docking of CD-61 with Tirofiban. The binding energy was more in latter than former. Conclusion: Amotosalen hydrochloride binds to the active site of CD-61 with weaker binding force. Haemorrhage seen in Amotosalen hydrochloride-treated platelets might be due to binding of Amotosalen hydrochloride to CD-61.
Publication Details
Page(s) 881-886
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 26, Issue: 11, Year: 2016

Request the full text from PASTIC

References
AndradeRG,RibeiroMA,Namen-LopesMS,SilvaSM,BasquesFV,RibasJG, 2010.Evaluation of the use of real-time PCR for human T-cell lymphotropic virus 1 and 2 as a confirmatory test in screening for blood donors,Rev Soc Bras Med Trop 43 111 -5
BlajchmanMA, 2002.Incidence and significance of the bacterial contamination of blood components,Dev Biol 108 59 -67
McDonaldCP,BlajchmanMA,BarbaraJAJ,ReganFAM,ContrerasMC, 2002.Bacterial contamination in blood and blood components,Transfusion Microbiology 87 -
StörmerM,VollmerT., 2014.Diagnostic methods for platelet bacteria screening: Current status and developments,Transfus Med Hemother 41 19 -27
PalavecinoE,YomtovianR, 2003.Risk and prevention of transfusion-related sepsis,Curr Opin Hematol 10 434 -9
DreierJ,StörmerM, 2004.Kleesiek K. Two novel real-time reverse transcriptase PCR assays for rapid detection of bacterial contamination in platelet concentrates,J Clin Microbiol 42 4759 -64
SusanneM., 2013.Current methods for the reduction of blood-borne pathogens: A comprehensive literature review,Blood Transfus 11 343 -8
SpringerTA,ZhuJ,XiaoT., 2008.Structural basis for distinctive recognition of fi brinogen γC peptide by the platelet integrin αIIbβ3,J Cell Biol 182 791 -800
Schneidman-DuhovnyD,InbarY,NussinovR,WolfsonHJ,DockP,DockS, 2005.Servers for rigid and symmetric docking,Nucleic Acids Res 33 W363 -7
MashiachE,Schneidman-DuhovnyD,AndrusierN,NussinovR,WolfsonHJ.,Dock, 2008.A web server for fast interaction refinement in molecular docking,Nucleic Acids Res 36 W229 -32
KerkhoffsJL,van PuttenWL,NovotnyVM,Te BoekhorstPA,SchipperusMR,ZwagingaJJ, 2010.Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction,Br J Haematol 150 209 -17
VamvakasEC, 2012.Meta-analysis of the studies of bleeding complications of platelets pathogen-reduced with the Intercept system,Vox Sang 102 302 -16
SlichterSJ,RaifeTJ,DavisK,RheinschmidtM,BuchholzDH,CorashL, 2006.Platelets photochemically treated with Amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia,Transfusion 46 731 -40
2014.Pathogen inactivation technologies for cellular blood components: An update,Transfus Med Hemother 41 309 -25
ParidaP,YadavRNS, 2012.Comparative docking study of M1 protein (influenza virus) to check drug efficacy,Int J Pharm Pharm Sci 4 243 -6
PatilR,DasS,StanleyA,YadavL,SudhakarA,VarmaAK, 2010.Optimized hydrophobic interactions and hydrogen bonding at the target-ligand interface leads the pathways of drugdesigning,PLoS One 5 e12029 -
YuanJ,RenJ,WangY,HeX,ZhaoY, 2016.Acteoside binds to caspase-3 and exerts neuroprotection in the rotenone rat model of parkinson's disease,PLoS One 11 e0162696 -
NguyenCT,TanakaK,CaoY,ChoSH,XuD,StaceyG, 2016.Computational analysis of the ligand binding site of the extracellular ATP receptor, DORN1,PLoS One 11 e0161894 -
SinghVK,KumarN,KalsanM,SainiA,ChandraR., 2016.A novel peptide thrombopoietin mimetic designing and optimization using computational approach,Front Bioeng Biotechnol 4 69 -
NusratS,SiddiqiMK,ZamanM,ZaidiN,AjmalMR,AlamP, 2016.A comprehensive spectroscopic and computational investigation to probe the interaction of antineoplastic drug nordihydroguaiaretic acid with serum albumins,PLoS One 7 e0158833 -
0

Citations

0

Downloads

99

Views